{"id":"W3025072273","doi":"10.3324/haematol.2019.238675","title":"Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas","year":2020,"lang":"en","type":"article","venue":"Haematologica","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"ca_institutions":"Spinal Cord Injury BC","funders":"National Cancer Institute","keywords":"Brentuximab vedotin; Medicine; Rituximab; Prednisone; Internal medicine; Cyclophosphamide; Oncology; Lymphoma; Vincristine; Regimen; B-cell lymphoma; CD30; Gastroenterology; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001205773,0.0007272776,0.001143248,0.00032499,0.000225717,0.0006261954,0.0007064171,0.0004439174,0.0008466004],"category_scores_gemma":[0.0006596992,0.0003284734,0.0005590972,0.0002877536,0.0003852307,0.000561383,0.0002331172,0.001613746,0.0002771719],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004847462,"about_ca_system_score_gemma":0.0005206178,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004977771,"about_ca_topic_score_gemma":0.001672886,"domain_scores_codex":[0.9996437,0.0001828372,0.00002499795,0.00005282934,0.00004456626,0.00005105582],"domain_scores_gemma":[0.9995641,0.00008337854,0.00008171736,0.00002927415,0.0000221532,0.0002193259],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.2716695,0.03034789,0.02462451,0.001398755,0.001645573,0.0008576448,0.0005184648,0.006206097,0.06191503,0.0003204021,0.004536814,0.5959592],"study_design_scores_gemma":[0.3738907,0.5378444,0.06057338,0.0001567183,0.001247584,0.0016792,0.0001302555,0.006172308,0.008818871,0.0002980677,0.009126871,0.00006154178],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911404,0.007126053,0.0003529902,0.0003160459,0.00008066655,0.0002388626,0.000132097,0.00004872144,0.0005640724],"genre_scores_gemma":[0.9943031,0.002935095,0.00113552,0.0003167449,0.0001491655,0.0002065766,0.0004200726,0.00001089681,0.0005229058],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001205773,"threshold_uncertainty_score":0.006376803,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01012370075675274,"score_gpt":0.2260793674792768,"score_spread":0.215955666722524,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}